Conclusion
By tracing the knowledge production and social life of Viartril-S in the United States, Europe, and Taiwan, this chapter proposes several concepts concerning food-drug regulation and the boundary between the two categories.
Specifically, this boundary is defined by the interaction between scientific evidence and regulatory frameworks. An object that belongs to one category can change categories and redefine the boundary when it is exchanged on the market. Second, knowledge production from clinical trials may not help clarify the blurred categories of foods and drugs. Third, modern regulatory frameworks largely dependent on classification and knowledge generated from such infrastructure may have difficulty regulating products that fall between the food and drug categories. Governing authorities must balance safety and effectiveness in their regulatory decisions or choose to prioritize one over the other.14
More on the topic Conclusion:
- CONCLUSION
- Conclusion
- Conclusion
- Conclusion
- 7.3 CONCLUSION
- Conclusion
- Conclusion
- Conclusion
- Conclusion
- Conclusion
- CONCLUSION
- CONCLUSION
- Conclusion
- Conclusion